Suraksha Diagnostic Limited is an India-based company. The Company is primarily engaged in the business of running diagnostic centers for carrying out various pathological and radiological services. The Company offers integrated solutions for pathology and radiology testing, and medical consultation services to its customers through its operational network. Its services include Imaging, Neurology, Cardiology, Gastroenterology, and Pathology. Its Imaging services include X-Ray, DEXA scan, USG scan, CT scan and others. Its Neurology services include EEG, EMG, NCV. Its Cardiology services include Echocardiogram Test, Stress Test / Treadmill Test, Holter Monitoring, Color Doppler, Peripheral Doppler, and others. Its Pathology services include Microbiology, Cytogenetic, Serology, Molecular Biology, Histopathology, Cytopathology, Haematology, and others. Its Gastroenterology services include Upper GI Endoscopy, Sigmoidoscopy, Colonoscopy, Proctoscopy, Proctosigmoidoscopy, and others. As of 25 May 2026, SURAKSHA DIAGNOSTIC LTD share price is ₹298.50. The stock opened at ₹310.00, compared to its previous close of ₹313.20. During today's trading session, SURAKSHA DIAGNOSTIC LTD share price moved in the range of ₹297.90 to ₹312.90, with an average price of ₹305.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹297.90 and a high of ₹312.90. On the performance front, SURAKSHA DIAGNOSTIC LTD share price has increased by 4.56% over the last six months and is down 3.39% on a year-on-year basis.
The market capitalization of SURAKSHA DIAGNOSTIC LTD is ₹1,614 Crs, with a P/E ratio of 51.4 and a dividend yield of 0.00%.